Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson's disease

被引:10
|
作者
Zhang, Feng [1 ]
Wang, Feng [2 ,3 ]
Li, Cong-Hui [1 ]
Wang, Ji-Wei [1 ]
Han, Chun-Lei [4 ]
Fan, Shi-Ying [4 ]
Gao, Dong-Mei [4 ]
Xing, Yu-Jing [1 ]
Yang, Chen [1 ]
Zhang, Jian-Guo [4 ]
Meng, Fan-Gang [4 ,5 ,6 ,7 ]
机构
[1] Hebei Med Univ, Hosp 1, Dept Neurosurg, Shijiazhuang 050031, Hebei, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China
[3] Ningxia Med Univ, Gen Hosp, Dept Neurosurg, Yinchuan 750004, Ningxia, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100070, Peoples R China
[5] Capital Med Univ, Beijing Neurosurg Inst, Beijing 100070, Peoples R China
[6] Beijing Key Lab Neurostimulat, Beijing 100070, Peoples R China
[7] Chinese Inst Brain Res, Beijing 102206, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; Deep brain stimulation; Subthalamic nucleus; Autonomic dysfunction; Non-motor symptoms; NONMOTOR SYMPTOMS; URINARY-BLADDER; LEVODOPA; IMPACT;
D O I
10.1186/s12883-022-02651-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background To study the effects of subthalamic nucleus-deep brain stimulation (STN-DBS) on autonomic dysfunctions in Parkinson's disease (PD) patients. Methods A total of 57 PD patients who underwent bilateral STN-DBS from March to December 2018, were retrospectively analyzed. Preplanned assessments at baseline and postoperatively at 1, 3, and 6 months also included the Scales for Outcomes in Parkinson's Disease-Autonomic questionnaire (SCOPA-Aut), the Unified Parkinson's Disease Rating Scale (UPDRS) III score, levodopa equivalent day dose (LEDD), Parkinson's Disease Quality of Life Scale (PDQ-39), the Hamilton Anxiety Rating Scale (HAMA), and the Hamilton Depression Rating Scale (HAMD). Results The SCOPA-Aut scores improved significantly [14.59% (18.32%), 24.00% (27.05%), 22.16% (27.07%), all P < 0.001] at 1 month, 3 months, and 6 months of STN-DBS, respectively. Analysis of the SCOPA-Aut sub-items showed significant improvements only in urine and thermoregulation sub-items at 6 months after surgery (P < 0.001). There was no significant correlation between improvements of SCOPA-Aut scores and improvements of PDQ-39 scores (P > 0.05) at 6 months after surgery. SCOPA-Aut scores were positively correlated with age (r = 0.428, P = 0.001); the improvements of SCCOPA-Aut scores were positively correlated with improvements of HAMA and HAMD scores (HAMA: r = 0.325, P = 0.015; HAMD: r = 0.265, P = 0.049) at 6 months after surgery. Conclusion STN-DBS improved autonomic dysfunction symptoms of PD patients, and urinary and thermoregulatory sub-items of autonomic dysfunction were improved in the short-term after surgery. There was a close relationship between improved autonomic symptoms and improved anxiety and depression 6 months after surgery. We should therefore direct more attention to autonomic dysfunctions in PD involving detailed preoperative evaluations and postoperative follow-ups, to improve the quality of life of patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease
    Bari, Ausaf A.
    Fasano, Alfonso
    Munhoz, Renato P.
    Lozano, Andres M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (10) : 1151 - 1160
  • [42] Functional Imaging of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
    Boertien, Tessel
    Zrinzo, Ludvic
    Kahan, Joshua
    Jahanshahi, Marjan
    Hariz, Marwan
    Mancini, Laura
    Limousin, Patricia
    Foltynie, Thomas
    MOVEMENT DISORDERS, 2011, 26 (10) : 1835 - 1843
  • [43] Subthalamic Nucleus Deep Brain Stimulation for Camptocormia Associated with Parkinson's disease
    Sako, Wataru
    Nishio, Masami
    Maruo, Tomoyuki
    Shimazu, Hideki
    Matsuzaki, Kazuhito
    Tamura, Tetsuya
    Mure, Hideo
    Ushio, Yukitaka
    Nagahiro, Shinji
    Kaji, Ryuji
    Goto, Satoshi
    MOVEMENT DISORDERS, 2009, 24 (07) : 1076 - 1079
  • [44] NEUROPSYCHIATRIC COMPLICATIONS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION FOR PARKINSON'S DISEASE
    Long, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 96 - 96
  • [45] Cognition and mood with subthalamic nucleus deep brain stimulation in Parkinson's disease
    Pedersen, P. M.
    Jorgensen, K.
    Lokkegaard, A.
    Regeur, L.
    Karlsborg, M.
    Werdelin, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 244 - 244
  • [46] Subthalamic nucleus deep brain stimulation and cognitive functions in Parkinson's disease
    Novakova, O.
    Spackova, N.
    Klempir, J.
    Jech, R.
    Roth, J.
    Urgosik, D.
    Ruzicka, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 94 - 94
  • [47] Eating disorders and deep brain stimulation of the subthalamic nucleus in Parkinson's Disease
    Chereau, I.
    De Chazeron, I.
    Rieu, I.
    Derost, P. P.
    Lemaire, J. J.
    Llorca, P. M.
    Durif, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S562 - S563
  • [48] Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease
    Charles, David
    Konrad, Peter E.
    Neimat, Joseph S.
    Molinari, Anna L.
    Tramontana, Michael G.
    Finder, Stuart G.
    Gill, Chandler E.
    Bliton, Mark J.
    Kao, Chris
    Phibbs, Fenna T.
    Hedera, Peter
    Salomon, Ronald M.
    Cannard, Kevin R.
    Wang, Lily
    Song, Yanna
    Davis, Thomas L.
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (07) : 731 - 737
  • [49] Effects of Directional Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's disease
    Tommasi, G.
    Bertolasi, L.
    Nicolato, A.
    Sala, F.
    Bonetti, B.
    Longhi, M.
    MOVEMENT DISORDERS, 2019, 34 : S881 - S881
  • [50] Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
    Witjas, T
    Baunez, C
    Henry, JM
    Delfini, M
    Regis, J
    Cherif, AA
    Peragut, JC
    Azulay, JP
    MOVEMENT DISORDERS, 2005, 20 (08) : 1052 - 1055